Novo Nordisk’s owner backs an Italian fund to grow drug startups beyond Denmark

Novo Holdings, the investment company that controls Novo Nordisk and holds the wealth of the Novo Nordisk Foundation, is backing a fund aimed at Italian drug startups, according to Bloomberg. The move extends a pattern that has seen the Danish investor push capital into life sciences hubs well outside Copenhagen, including European deep-tech vehicles backed alongside the […] This story continues at The Next Web

This story was reported by The Next Web. EUROPES curates Europe's most relevant coverage — read the full report at the original source.